Turning Point Therapeutics Inc. (TPTX) PT Raised to $155 at Wedbush, Following Earnings

January 29, 2021 2:58 PM EST
Get Alerts TPTX Hot Sheet
Price: $62.88 -4.47%

Rating Summary:
    11 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten raised the price target on Turning Point Therapeutics Inc. (NASDAQ: TPTX) to $155.00 (from $136.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Earnings